Proteomic profiling of potential molecular targets of methyl-selenium compounds in the transgenic adenocarcinoma of mouse prostate model.

Zhang, Jinhui

Proteomic profiling of potential molecular targets of methyl-selenium compounds in the transgenic adenocarcinoma of mouse prostate model. [electronic resource] - Cancer prevention research (Philadelphia, Pa.) Aug 2010 - 994-1006 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1940-6215

10.1158/1940-6207.CAPR-09-0261 doi


Adenocarcinoma--drug therapy
Animals
Biomarkers, Pharmacological--analysis
Biomarkers, Tumor--analysis
Cysteine--analogs & derivatives
Disease Models, Animal
Male
Metabolome--drug effects
Mice
Mice, Inbred C57BL
Mice, Transgenic
Models, Biological
Organoselenium Compounds--pharmacokinetics
Prostatic Neoplasms--drug therapy
Proteomics--methods
Selenium Compounds--pharmacokinetics
Selenocysteine--analogs & derivatives
Selenomethionine--pharmacokinetics